Global Cancer News

Cancer Research UK announces drug discovery collaboration with Celgene Corporation

Anne Li

Cancer Research UK announced on Friday, December 15th, the signing of a five-year drug-discovery collaboration between its subsidiary, Cancer Research Technology (CRT), and Celgene Corporation, to discover, develop and commercialise new anti-cancer treatments. This arrangement represents an expansion of Cancer Research Technology’s theme-based translational model that now encompasses six industry partnerships, including this new collaboration with Celgene.

See original article at:

Post a comment